REFERENCES
R. L. Siegel, K. D. Miller, H. E. Fuchs,A. Jemal, Cancer Statistics,
2021. (2021).CA Cancer J Clin,1,
7-33.http://dx.doi.org/10.3322/caac.21654
M. S. Litwin,H. J. Tan, The Diagnosis and Treatment of Prostate Cancer:
A Review. (2017).Jama,24,
2532-2542.http://dx.doi.org/10.1001/jama.2017.7248
P. A. Watson, V. K. Arora,C. L. Sawyers, Emerging mechanisms of
resistance to androgen receptor inhibitors in prostate cancer.
(2015).Nat Rev Cancer,12,
701-11.http://dx.doi.org/10.1038/nrc4016
R. Gao, D. K. Price, W. L. Dahut, E. Reed,W. D. Figg, Genetic
polymorphisms in XRCC1 associated with radiation therapy in prostate
cancer. (2010).Cancer Biol Ther,1,
13-8.http://dx.doi.org/10.4161/cbt.10.1.12172
K. Ruggero, S. Farran-Matas, A. Martinez-Tebar,A. Aytes, Epigenetic
Regulation in Prostate Cancer Progression. (2018).Curr Mol Biol Rep,2,
101-115.http://dx.doi.org/10.1007/s40610-018-0095-9
K. Arita, S. Isogai, T. Oda, M. Unoki, K. Sugita, N. Sekiyama, K.
Kuwata, R. Hamamoto, H. Tochio, M. Sato, M. Ariyoshi,M. Shirakawa,
Recognition of modification status on a histone H3 tail by linked
histone reader modules of the epigenetic regulator UHRF1. (2012).Proc
Natl Acad Sci U S A,32,
12950-5.http://dx.doi.org/10.1073/pnas.1203701109
S. A. Bert, M. D. Robinson, D. Strbenac, A. L. Statham, J. Z. Song, T.
Hulf, R. L. Sutherland, M. W. Coolen, C. Stirzaker,S. J. Clark, Regional
activation of the cancer genome by long-range epigenetic remodeling.
(2013).Cancer Cell,1,
9-22.http://dx.doi.org/10.1016/j.ccr.2012.11.006
D. Patnaik, P. O. Estève,S. Pradhan, Targeting the SET and
RING-associated (SRA) domain of ubiquitin-like, PHD and ring
finger-containing 1 (UHRF1) for anti-cancer drug development.
(2018).Oncotarget,40,
26243-26258.http://dx.doi.org/10.18632/oncotarget.25425
J. Yang, K. Liu, J. Yang, B. Jin, H. Chen, X. Zhan, Z. Li, L. Wang, X.
Shen, M. Li, W. Yu,Z. Mao, PIM1 induces cellular senescence through
phosphorylation of UHRF1 at Ser311. (2017).Oncogene,34,
4828-4842.http://dx.doi.org/10.1038/onc.2017.96
H. Chen, H. Ma, H. Inuzuka, J. Diao, F. Lan, Y. G. Shi, W. Wei,Y. Shi,
DNA damage regulates UHRF1 stability via the SCF(β-TrCP) E3 ligase.
(2013).Mol Cell Biol,6,
1139-48.http://dx.doi.org/10.1128/mcb.01191-12
A. Beck, F. Trippel, A. Wagner, S. Joppien, M. Felle, C. Vokuhl, T.
Schwarzmayr, T. M. Strom, D. von Schweinitz, G. Langst,R. Kappler,
Overexpression of UHRF1 promotes silencing of tumor suppressor genes and
predicts outcome in hepatoblastoma. (2018).Clin
Epigenetics,27.http://dx.doi.org/10.1186/s13148-018-0462-7
H. J. Jung, H. O. Byun, B. A. Jee, S. Min, U. W. Jeoun, Y. K. Lee, Y.
Seo, H. G. Woo,G. Yoon, The Ubiquitin-like with PHD and Ring Finger
Domains 1 (UHRF1)/DNA Methyltransferase 1 (DNMT1) Axis Is a Primary
Regulator of Cell Senescence. (2017).J Biol Chem,9,
3729-3739.http://dx.doi.org/10.1074/jbc.M116.750539
P. A. Pérez-Mancera, A. R. Young,M. Narita, Inside and out: the
activities of senescence in cancer. (2014).Nat Rev Cancer,8,
547-58.http://dx.doi.org/10.1038/nrc3773
X. L. Su, J. W. Wang, H. Che, C. F. Wang, H. Jiang, X. Lei, W. Zhao, H.
X. Kuang,Q. H. Wang, Clinical application and mechanism of traditional
Chinese medicine in treatment of lung cancer. (2020).Chin Med J
(Engl),24,
2987-2997.http://dx.doi.org/10.1097/CM9.0000000000001141
M. J. Hsieh, M. K. Chen, Y. Y. Yu, G. T. Sheu,H. L. Chiou, Psoralen
reverses docetaxel-induced multidrug resistance in A549/D16 human lung
cancer cells lines. (2014).Phytomedicine,7,
970-7.http://dx.doi.org/10.1016/j.phymed.2014.03.008
L. Zhang, B. Yan, S. Meng, L. Zhou, Y. Xu, W. Du,L. Shan, Theaflavin
Induces Apoptosis of A375 Human Melanoma Cells and Inhibits Tumor Growth
in Xenograft Zebrafishes Through P53- and JNK-Related Mechanism.
(2020).Front
Pharmacol,1317.http://dx.doi.org/10.3389/fphar.2020.01317
P. Duan,Z. M. Wang, [Clinical study on effect of Astragalus in
efficacy enhancing and toxicity reducing of chemotherapy in patients of
malignant tumor]. (2002).Zhongguo Zhong Xi Yi Jie He Za Zhi,7,
515-7.http://dx.doi.org/
Y. Zhang, Z. Wu, H. Yu, H. Wang, G. Liu, S. Wang,X. Ji, Chinese Herbal
Medicine Wenxia Changfu Formula Reverses Cell Adhesion-Mediated Drug
Resistance via the Integrin beta1-PI3K-AKT Pathway in Lung Cancer.
(2019).J Cancer,2,
293-304.http://dx.doi.org/10.7150/jca.25163
D. H. J. Cheong, D. W. S. Tan, F. W. S. Wong,T. Tran, Anti-malarial
drug, artemisinin and its derivatives for the treatment of respiratory
diseases. (2020).Pharmacol
Res,104901.http://dx.doi.org/10.1016/j.phrs.2020.104901
H. S. Kim, E. H. Lee, S. R. Ko, K. J. Choi, J. H. Park,D. S. Im, Effects
of ginsenosides Rg3 and Rh2 on the proliferation of prostate cancer
cells. (2004).Arch Pharm Res,4,
429-35.http://dx.doi.org/10.1007/bf02980085
H. Wang, Y. Zheng, Q. Sun, Z. Zhang, M. Zhao, C. Peng,S. Shi,
Ginsenosides emerging as both bifunctional drugs and nanocarriers for
enhanced antitumor therapies. (2021).J Nanobiotechnology,1,
322.http://dx.doi.org/10.1186/s12951-021-01062-5
D. Zhang, Y. Chu, H. Qian, L. Qian, J. Shao, Q. Xu, L. Yu, R. Li, Q.
Zhang, F. Wu, B. Liu,Q. Liu, Antitumor Activity of Thermosensitive
Hydrogels Packaging Gambogic Acid Nanoparticles and Tumor-Penetrating
Peptide iRGD Against Gastric Cancer. (2020).Int J
Nanomedicine,735-747.http://dx.doi.org/10.2147/IJN.S231448
D. J. Newman,G. M. Cragg, Natural Products as Sources of New Drugs from
1981 to 2014. (2016).J Nat Prod,3,
629-61.http://dx.doi.org/10.1021/acs.jnatprod.5b01055
M. Krifa, L. Leloup, K. Ghedira, M. Mousli,L. Chekir-Ghedira, Luteolin
induces apoptosis in BE colorectal cancer cells by downregulating
calpain, UHRF1, and DNMT1 expressions. (2014).Nutr Cancer,7,
1220-7.http://dx.doi.org/10.1080/01635581.2014.951729
M. Achour, M. Mousli, M. Alhosin, A. Ibrahim, J. Peluso, C. D. Muller,
V. B. Schini-Kerth, A. Hamiche, S. Dhe-Paganon,C. Bronner,
Epigallocatechin-3-gallate up-regulates tumor suppressor gene expression
via a reactive oxygen species-dependent down-regulation of UHRF1.
(2013).Biochem Biophys Res Commun,1,
208-12.http://dx.doi.org/10.1016/j.bbrc.2012.11.087
M. Alhosin, A. Abusnina, M. Achour, T. Sharif, C. Muller, J. Peluso, T.
Chataigneau, C. Lugnier, V. B. Schini-Kerth, C. Bronner,G. Fuhrmann,
Induction of apoptosis by thymoquinone in lymphoblastic leukemia Jurkat
cells is mediated by a p73-dependent pathway which targets the
epigenetic integrator UHRF1. (2010).Biochem Pharmacol,9,
1251-60.http://dx.doi.org/10.1016/j.bcp.2009.12.015
M. Krifa, M. Alhosin, C. D. Muller, J. P. Gies, L. Chekir-Ghedira, K.
Ghedira, Y. Mély, C. Bronner,M. Mousli, Limoniastrum guyonianum aqueous
gall extract induces apoptosis in human cervical cancer cells involving
p16 INK4A re-expression related to UHRF1 and DNMT1 down-regulation.
(2013).J Exp Clin Cancer Res,1,
30.http://dx.doi.org/10.1186/1756-9966-32-30
T. Sharif, C. Auger, M. Alhosin, C. Ebel, M. Achour, N. Etienne-Selloum,
G. Fuhrmann, C. Bronner,V. B. Schini-Kerth, Red wine polyphenols cause
growth inhibition and apoptosis in acute lymphoblastic leukaemia cells
by inducing a redox-sensitive up-regulation of p73 and down-regulation
of UHRF1. (2010).Eur J Cancer,5,
983-94.http://dx.doi.org/10.1016/j.ejca.2009.12.029
M. Alhosin, A. J. León-González, I. Dandache, A. Lelay, S. K. Rashid, C.
Kevers, J. Pincemail, L. M. Fornecker, L. Mauvieux, R. Herbrecht,V. B.
Schini-Kerth, Bilberry extract (Antho 50) selectively induces
redox-sensitive caspase 3-related apoptosis in chronic lymphocytic
leukemia cells by targeting the Bcl-2/Bad pathway. (2015).Sci
Rep,8996.http://dx.doi.org/10.1038/srep08996
M. Chow, L. Gao, J. D. MacManiman, V. T. Bicocca, B. H. Chang, J. J.
Alumkal,J. W. Tyner, Maintenance and pharmacologic targeting of ROR1
protein levels via UHRF1 in t(1;19) pre-B-ALL. (2018).Oncogene,38,
5221-5232.http://dx.doi.org/10.1038/s41388-018-0299-8
J. S. Seo, Y. H. Choi, J. W. Moon, H. S. Kim,S. H. Park, Hinokitiol
induces DNA demethylation via DNMT1 and UHRF1 inhibition in colon cancer
cells. (2017).BMC Cell Biol,1,
14.http://dx.doi.org/10.1186/s12860-017-0130-3
Z. Tang, C. Li, B. Kang, G. Gao, C. Li,Z. Zhang, GEPIA: a web server for
cancer and normal gene expression profiling and interactive analyses.
(2017).Nucleic Acids Res,W1,
W98-W102.http://dx.doi.org/10.1093/nar/gkx247
J. Ru, P. Li, J. Wang, W. Zhou, B. Li, C. Huang, P. Li, Z. Guo, W. Tao,
Y. Yang, X. Xu, Y. Li, Y. Wang,L. Yang, TCMSP: a database of systems
pharmacology for drug discovery from herbal medicines. (2014).J
Cheminform,13.http://dx.doi.org/10.1186/1758-2946-6-13
A. wanli,Y. hong, Analysis on the regularity of prescription of
traditional Chinese medicine for the treatment of prostate cancer.
(2018).Pharmacovigilance in China,03,
158-162.http://dx.doi.org/
O. Trott,A. J. Olson, AutoDock Vina: improving the speed and accuracy of
docking with a new scoring function, efficient optimization, and
multithreading. (2010).J Comput Chem,2,
455-61.http://dx.doi.org/10.1002/jcc.21334
G. Lagger, D. O’Carroll, M. Rembold, H. Khier, J. Tischler, G. Weitzer,
B. Schuettengruber, C. Hauser, R. Brunmeir, T. Jenuwein,C. Seiser,
Essential function of histone deacetylase 1 in proliferation control and
CDK inhibitor repression. (2002).Embo j,11,
2672-81.http://dx.doi.org/10.1093/emboj/21.11.2672
H. Ma, H. Chen, X. Guo, Z. Wang, M. E. Sowa, L. Zheng, S. Hu, P. Zeng,
R. Guo, J. Diao, F. Lan, J. W. Harper, Y. G. Shi, Y. Xu,Y. Shi, M phase
phosphorylation of the epigenetic regulator UHRF1 regulates its physical
association with the deubiquitylase USP7 and stability. (2012).Proc Natl
Acad Sci U S A,13,
4828-33.http://dx.doi.org/10.1073/pnas.1116349109
Y. Liu, G. Liang, T. Zhou,Z. Liu, Silencing UHRF1 Inhibits Cell
Proliferation and Promotes Cell Apoptosis in Retinoblastoma Via the
PI3K/Akt Signalling Pathway. (2020).Pathol Oncol Res,2,
1079-1088.http://dx.doi.org/10.1007/s12253-019-00656-7
X. Kong, J. Chen, W. Xie, S. M. Brown, Y. Cai, K. Wu, D. Fan, Y. Nie, S.
Yegnasubramanian, R. L. Tiedemann, Y. Tao, R. W. Chiu Yen, M. J. Topper,
C. A. Zahnow, H. Easwaran, S. B. Rothbart, L. Xia,S. B. Baylin, Defining
UHRF1 Domains that Support Maintenance of Human Colon Cancer DNA
Methylation and Oncogenic Properties. (2019a).Cancer Cell,4, 633-648
e7.http://dx.doi.org/10.1016/j.ccell.2019.03.003
W. Zhang,J. Xu, DNA methyltransferases and their roles in tumorigenesis.
(2017).Biomark
Res,1.http://dx.doi.org/10.1186/s40364-017-0081-z
A. Scott, F. Bai, H. L. Chan, S. Liu, J. M. Slingerland, D. J. Robbins,
A. J. Capobianco,X. H. Pei, p16 loss rescues functional decline of
Brca1-deficient mammary stem cells. (2017).Cell Cycle,8,
759-764.http://dx.doi.org/10.1080/15384101.2017.1295185
H. Chen, X. Liu, W. Zhu, H. Chen, X. Hu, Z. Jiang, Y. Xu, L. Wang, Y.
Zhou, P. Chen, N. Zhang, D. Hu, L. Zhang, Y. Wang, Q. Xu, R. Wu, H.
Yu,J. Wang, SIRT1 ameliorates age-related senescence of mesenchymal stem
cells via modulating telomere shelterin. (2014).Front Aging
Neurosci,103.http://dx.doi.org/10.3389/fnagi.2014.00103
A. Sharma, A. K. Verma, M. Kofron, R. Kudira, A. Miethke, T. Wu, J.
Wang,C. R. Gandhi, Lipopolysaccharide Reverses Hepatic Stellate Cell
Activation Through Modulation of cMyb, Small Mothers Against
Decapentaplegic, and CCAAT/Enhancer-Binding Protein C/EBP Transcription
Factors. (2020).Hepatology,5,
1800-1818.http://dx.doi.org/10.1002/hep.31188
D. Hanahan,R. A. Weinberg, Hallmarks of cancer: the next generation.
(2011).Cell,5,
646-74.http://dx.doi.org/10.1016/j.cell.2011.02.013
M. Yamashita, K. Inoue, N. Saeki, M. Ideta-Otsuka, Y. Yanagihara, Y.
Sawada, I. Sakakibara, J. Lee, K. Ichikawa, Y. Kamei, T. Iimura, K.
Igarashi, Y. Takada,Y. Imai, Uhrf1 is indispensable for normal limb
growth by regulating chondrocyte differentiation through specific gene
expression. (2018).Development,1, 10.1242/dev.157412
M. Mancini, E. Magnani, F. Macchi,I. M. Bonapace, The
multi-functionality of UHRF1: epigenome maintenance and preservation of
genome integrity. (2021).Nucleic Acids Res,11,
6053-6068.http://dx.doi.org/10.1093/nar/gkab293
W. Ashraf, A. Ibrahim, M. Alhosin, L. Zaayter, K. Ouararhni, C. Papin,
T. Ahmad, A. Hamiche, Y. Mély, C. Bronner,M. Mousli, The epigenetic
integrator UHRF1: on the road to become a universal biomarker for
cancer. (2017).Oncotarget,31,
51946-51962.http://dx.doi.org/10.18632/oncotarget.17393
X. Kong, J. Chen, W. Xie, S. M. Brown, Y. Cai, K. Wu, D. Fan, Y. Nie, S.
Yegnasubramanian, R. L. Tiedemann, Y. Tao, R. W. Chiu Yen, M. J. Topper,
C. A. Zahnow, H. Easwaran, S. B. Rothbart, L. Xia,S. B. Baylin, Defining
UHRF1 Domains that Support Maintenance of Human Colon Cancer DNA
Methylation and Oncogenic Properties. (2019b).Cancer Cell,4,
633-648.e7.http://dx.doi.org/10.1016/j.ccell.2019.03.003
M. Felle, S. Joppien, A. Nemeth, S. Diermeier, V. Thalhammer, T. Dobner,
E. Kremmer, R. Kappler,G. Langst, The USP7/Dnmt1 complex stimulates the
DNA methylation activity of Dnmt1 and regulates the stability of UHRF1.
(2011).Nucleic Acids Res,19,
8355-65.http://dx.doi.org/10.1093/nar/gkr528
A. P. Turnbull, S. Ioannidis, W. W. Krajewski, A. Pinto-Fernandez, C.
Heride, A. C. L. Martin, L. M. Tonkin, E. C. Townsend, S. M. Buker, D.
R. Lancia, J. A. Caravella, A. V. Toms, T. M. Charlton, J. Lahdenranta,
E. Wilker, B. C. Follows, N. J. Evans, L. Stead, C. Alli, V. V.
Zarayskiy, A. C. Talbot, A. J. Buckmelter, M. Wang, C. L. McKinnon, F.
Saab, J. F. McGouran, H. Century, M. Gersch, M. S. Pittman, C. G.
Marshall, T. M. Raynham, M. Simcox, L. M. D. Stewart, S. B. McLoughlin,
J. A. Escobedo, K. W. Bair, C. J. Dinsmore, T. R. Hammonds, S. Kim, S.
Urbe, M. J. Clague, B. M. Kessler,D. Komander, Molecular basis of USP7
inhibition by selective small-molecule inhibitors. (2017).Nature,7677,
481-486.http://dx.doi.org/10.1038/nature24451